-
CNCR Dashboard
- Holdings
Range Cancer Therapeutics ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
RXRX Recursion Pharmaceuticals, Inc. | 358.88 k | 50.76 k shares | 3.02 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics, Inc. | 308.71 k | 29.80 k shares | 2.60 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 241.84 k | 47.98 k shares | 2.03 | Common equity | Long | USA |
DNA Ginkgo Bioworks Holdings, Inc. | 233.86 k | 26.88 k shares | 1.97 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 225.42 k | 16.01 k shares | 1.90 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 222.26 k | 6.10 k shares | 1.87 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 217.52 k | 3.76 k shares | 1.83 | Common equity | Long | USA |
XNCR Xencor, Inc. | 202.70 k | 7.92 k shares | 1.71 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 198.39 k | 3.35 k shares | 1.67 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 195.33 k | 4.71 k shares | 1.64 | Common equity | Long | USA |
MRSN Mersana Therapeutics, Inc. | 193.81 k | 85.01 k shares | 1.63 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 191.55 k | 2.17 k shares | 1.61 | Common equity | Long | USA |
SDGR Schrödinger, Inc. | 190.31 k | 8.43 k shares | 1.60 | Common equity | Long | USA |
Zymeworks Inc. | 188.61 k | 13.39 k shares | 1.59 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 186.98 k | 1.94 k shares | 1.57 | Common equity | Long | USA |
KPTI Karyopharm Therapeutics Inc. | 184.90 k | 218.79 k shares | 1.56 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 182.44 k | 7.48 k shares | 1.53 | Common equity | Long | USA |
CRBU Caribou Biosciences, Inc. | 180.66 k | 82.49 k shares | 1.52 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 177.93 k | 6.66 k shares | 1.50 | Common equity | Long | USA |
GNLX Genelux Corporation | 177.35 k | 65.93 k shares | 1.49 | Common equity | Long | USA |
MGNX MacroGenics, Inc. | 175.27 k | 48.82 k shares | 1.47 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 171.72 k | 10.13 k shares | 1.44 | Common equity | Long | Hong Kong |
DAWN Day One Biopharmaceuticals, Inc. | 171.14 k | 12.29 k shares | 1.44 | Common equity | Long | USA |
ERAS Erasca, Inc. | 169.84 k | 59.38 k shares | 1.43 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 166.16 k | 5.08 k shares | 1.40 | Common equity | Long | UK |
RPTX Repare Therapeutics Inc. | 165.45 k | 50.44 k shares | 1.39 | Common equity | Long | Canada |
ZNTL Zentalis Pharmaceuticals, Inc. | 164.28 k | 45.51 k shares | 1.38 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 161.82 k | 3.45 k shares | 1.36 | Common equity | Long | USA |
BNTX BioNTech SE | 160.54 k | 1.36 k shares | 1.35 | Common equity | Long | Germany |
CMPX Compass Therapeutics, Inc. | 159.63 k | 97.93 k shares | 1.34 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 159.10 k | 17.07 k shares | 1.34 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 158.19 k | 54.55 k shares | 1.33 | Common equity | Long | USA |
GERN Geron Corporation | 157.88 k | 38.32 k shares | 1.33 | Common equity | Long | USA |
AURA Aura Biosciences, Inc. | 156.38 k | 16.80 k shares | 1.32 | Common equity | Long | USA |
PGEN Precigen, Inc. | 156.12 k | 167.50 k shares | 1.31 | Common equity | Long | USA |
ACRV Acrivon Therapeutics, Inc. Common Stock | 154.24 k | 20.35 k shares | 1.30 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 153.84 k | 9.20 k shares | 1.29 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 153.43 k | 12.87 k shares | 1.29 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 152.99 k | 9.91 k shares | 1.29 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 151.93 k | 20.99 k shares | 1.28 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 151.77 k | 3.36 k shares | 1.28 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 150.47 k | 60.68 k shares | 1.27 | Common equity | Long | USA |
MRUS Merus N.V. | 149.59 k | 3.34 k shares | 1.26 | Common equity | Long | Netherlands |
Inhibrx Biosciences, Inc. | 146.62 k | 9.61 k shares | 1.23 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 145.55 k | 6.58 k shares | 1.22 | Common equity | Long | USA |
FHTX Foghorn Therapeutics Inc. | 144.50 k | 18.09 k shares | 1.22 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 144.34 k | 1.49 k shares | 1.21 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 144.33 k | 1.42 k shares | 1.21 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 139.00 k | 41.87 k shares | 1.17 | Common equity | Long | UK |
TSVT 2seventy bio, Inc. | 138.92 k | 34.82 k shares | 1.17 | Common equity | Long | USA |
VOR Vor Biopharma Inc. | 137.97 k | 165.81 k shares | 1.16 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 137.36 k | 3.27 k shares | 1.16 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 136.82 k | 6.71 k shares | 1.15 | Common equity | Long | UK |
GMAB Genmab A/S | 135.45 k | 6.30 k shares | 1.14 | Common equity | Long | Denmark |
FATE Fate Therapeutics, Inc. | 134.06 k | 42.29 k shares | 1.13 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 133.03 k | 9.89 k shares | 1.12 | Common equity | Long | USA |
TYRA Tyra Biosciences, Inc. | 130.32 k | 8.31 k shares | 1.10 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 127.64 k | 135.05 k shares | 1.07 | Common equity | Long | USA |
ACET Adicet Bio, Inc. | 126.16 k | 111.64 k shares | 1.06 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 124.41 k | 4.55 k shares | 1.05 | Common equity | Long | USA |
IMRX Immuneering Corporation | 121.95 k | 58.35 k shares | 1.03 | Common equity | Long | USA |
STRO Sutro Biopharma, Inc. | 119.94 k | 45.26 k shares | 1.01 | Common equity | Long | USA |
IPHA Innate Pharma S.A. | 119.12 k | 77.35 k shares | 1.00 | Common equity | Long | France |
ITOS iTeos Therapeutics, Inc. | 118.33 k | 13.84 k shares | 1.00 | Common equity | Long | USA |
RAPT RAPT Therapeutics, Inc. | 112.24 k | 89.08 k shares | 0.94 | Common equity | Long | USA |
APLM Apollomics, Inc. | 112.06 k | 12.59 k shares | 0.94 | Common equity | Long | USA |
IMTX Immatics N.V. | 109.45 k | 13.16 k shares | 0.92 | Common equity | Long | Germany |
REGN Regeneron Pharmaceuticals, Inc. | 108.78 k | 145.00 shares | 0.92 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 106.14 k | 10.57 k shares | 0.89 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 104.87 k | 5.68 k shares | 0.88 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 97.05 k | 20.65 k shares | 0.82 | Common equity | Long | USA |
AGEN Agenus Inc. | 94.20 k | 27.54 k shares | 0.79 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 88.58 k | 8.02 k shares | 0.75 | Common equity | Long | USA |
First American Government Obligations Fund | 87.15 k | 87.15 k shares | 0.73 | Short-term investment vehicle | Long | USA |
TNGX Tango Therapeutics, Inc. | 68.66 k | 17.43 k shares | 0.58 | Common equity | Long | USA |
PRLD Prelude Therapeutics Incorporated | 67.63 k | 64.41 k shares | 0.57 | Common equity | Long | USA |